← All stocks

MiNK Therapeutics, Inc.

INKT Net buying
CIK 0001840229 #4632 in the set updated 21 Sep 2026
Bought (120 mo)
$17.62M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$141.47K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$141.47K
9 of 9 sales
Net
+$17.48M
+$17.48M against sales at will

By person

11 insiders · 26 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
AGENUS INC entity
10% owner
$17.49M (14)
+$17.49M
21,772,863
$278.68M
−28.1%
Ryan Barbara
Director
$46.62K (8)
−$46.62K
23,591
$301.95K
WIINBERG ULF
Director
$27.65K (2)
+$27.65K
51,759
$662.49K
ARMEN GARO H
Director
$94.85K (1)
$94.85K (1)
$0.00
1,866,400
$23.89M
0.0%
Buell Jennifer
Chief Executive Officer
67,966
$869.93K
Corvese Brian
Director
54,770
$701.03K
Baldoni John
Director
41,193
$527.25K
van Dijk Marcus Antonius
Chief Scientific Officer
27,363
$350.23K
Behner Peter
Director
24,404
$312.36K
Kadlec Robert Peter
Director
19,126
$244.80K
+1,457%
Holcomb John Bradley
Director
4,691
$60.04K

No percentages here. This company's share count has moved by a factor of 10.0 over the window, from 3,966,392 to 39,549,975 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Ryan Barbara
4 Jun 2026
Director
Sell
1,000
$12.80
$12.80K
Ryan Barbara
4 Jun 2026
Director
Sell
500
$12.68
$6.34K
Ryan Barbara
10 Mar 2026
Director
Sell
500
$15.30
$7.65K
Ryan Barbara
10 Mar 2026
Director
Sell
500
$15.57
$7.78K
Ryan Barbara
10 Mar 2026
Director
Sell
300
$15.28
$4.58K
Ryan Barbara
9 Mar 2026
Director
Sell
200
$10.17
$2.03K
Ryan Barbara
2 Mar 2026
Director
Sell
100
$10.83
$1.08K
Ryan Barbara
27 Feb 2026
Director
Sell
400
$10.86
$4.34K
ARMEN GARO H
5 May 2023
Director
Sell
100,000
$0.95
$94.85K

What was left out

Form 4 filings counted 124
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 12,943,552
History held since 20 Oct 2021